©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109055
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109055
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109055
Table 2 Distribution and intensity of pancreatic adenocarcinoma upregulated factor positivity
| Intensity | Proportion of PAUF staining | Total | ||||||||||
| 0 | 1-4 | 5-10 | 11-20 | 21-30 | 31-40 | 41-50 | 51-60 | 61-70 | 71-80 | 81-90 | ||
| 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 |
| 1+ | 0 | 6 | 22 | 7 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 38 |
| 2+ | 0 | 5 | 22 | 2 | 4 | 1 | 1 | 3 | 0 | 0 | 1 | 39 |
| Total | 16 | 11 | 44 | 9 | 6 | 1 | 1 | 3 | 0 | 0 | 2 | 93 |
| Cumulative number (%) | 16 (17.2) | 27 (29.0) | 71 (76.3) | 80 (86.0) | 86 (92.5) | 87 (93.5) | 88 (94.6) | 91 (97.8) | 91 (97.8) | 91 (97.8) | 93 (100) | 93 |
- Citation: Kim JH, Na HY, Jung K, Jang D, Youn Y, Kim DH, Han HD, Hwang JH. Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic cancer and its prognostic significance. World J Gastrointest Oncol 2025; 17(9): 109055
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109055.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109055